ugichem Receives €2.25 Million funding for Antisense Drug Platform

News   May 29, 2013

 
ugichem Receives €2.25 Million funding for Antisense Drug Platform
 
 
 
FURTHER INFORMATION
 

Like what you just read? You can find similar content on the communities below.

Cell Science Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 
 

Comments | 0 ADD COMMENT